Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes.

<h4>Introduction</h4>Despite continuous efforts, not a single predictor of breast cancer chemotherapy resistance has made it into the clinic yet. However, it has become clear in recent years that breast cancer is a collection of molecularly distinct diseases. With ever increasing amounts...

Full description

Bibliographic Details
Main Authors: Jorma J de Ronde, Marc Jan Bonder, Esther H Lips, Sjoerd Rodenhuis, Lodewyk F A Wessels
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24558399/?tool=EBI